Investorideas.com  big ideas for global investors Search www.investorideas.com
   Member Access       Sign-up       Newsfeeds        Companies        Stock Directories       Research       Video       Funding   




NASDAQ Movers; (CBAN), (ADEP), (HALO), (CXPO)

Category: Investment

Ideas get bigger when you share them...

Visit: Adept Technology Inc.

New York, New York - January 14, 2013 (www.investorideas.com newswire) Investorideas.com staff: Investorideas.com, an investor research portal specializing in sector research for independent investors reports on the top percentage gainers on the NASDAQ for January 14th, 2013.

Join Investor Ideas Members to access the Renewable Energy stocks directory, water stocks, biotech stocks, defense stocks directories and the Insiders Corner

Colony Bankcorp Inc., (NASDAQ:CBAN) trading at $5.25 gained $0.88 or 20.14% on a light volume of 25,240 shares.

Adept Technology Inc., (NASDAQ:ADEP) trading at $3.9299 moved up $0.62 or 18.73% on a volume of 405,985 shares.

Adept Technology (ADEP), which sells industrial robots and other factory automation systems, rose following an appearance by CEO John Dulchinos on this weekend's edition of 60 Minutes. During his appearance, Dulchinos said U.S. manufacturers can leverage technology like that offered by Adept to equalize the costs of manufacturing in the U.S. compared to global competition. Dulchinos added that robots and automation may make it more likely that U.S. companies will find it beneficial to keep factories in the country or move them back here

Halozyme Therapeutics Inc., (NASDAQ:HALO) trading at $8.20 rose by $0.99 or 13.73% on a volume of 1,277,114 shares.

Halozyme Therapeutics (HALO) began rising and will likely move higher after an upgrade from BMO Capital Markets from Neutral to Outperform. The analyst's price target was raised from $4.00 to $12.00 per share; this is mostly due to the company expecting to see its first major product (in collaboration with Roche) hit the market in the next several months.

Roche (RHHBY.OB) expects to receive European approval of its SC Herceptin drug (Roche's $6 billion cancer treatment combined with Halozyme's subcutaneous delivery technology) this quarter, and could launch the drug before mid-year.

Crimson Exploration Inc., (NASDAQ:CXPO) trading at $3.12 gained $0.32 or 11.43% on a volume of 227,308 shares.

About NASDAQ

http://www.nasdaq.com/

About InvestorIdeas.com:

InvestorIdeas.com is a leader in investor stock research by sector, featuring stock news, commentary and trading alerts in leading sectors including biotech, tech, mining, energy, water, renewable energy, beverage stocks and more .

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas

Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas

Follow Investorideas.com News on Linkedin.com/today at http://www.linkedin.com/today/investorideas.com

Sign up for the free investor news and stock alerts at Investorideas.com

http://www.investorideas.com/Resources/Newsletter.asp

Become an Investorideas.com Member and access our 14 online stock directories 24/7 - water, renewable energy, mining stocks and more…

http://www.investorideas.com/membership/

Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.

BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

800-665-0411 - Source - www.Investorideas.com


Free News Alerts
Email:  

Read more News





TOP

Investor Ideas © 2000 - 2014 InvestorIdeas.com®, ECON

Free Investor Stock Alerts
Sign up here

login | logout | about us | contact | disclaimer / disclosure |
advertise | company profile directory | partners / links |
job search | privacy policy | trade | services | sitemap |